eli lilly sleep apnea news

obstructive sleep apnea, obesity and Zepbound

Lilly Rises on FDA Approval of Weight-Loss Drug Zepbound for Sleep Apnea

Key Takeaways Eli Lilly's Zepbound has been approved by the Food and Drug Administration (FDA) as a treatment for adults with sleep apnea and obesity, the drugmaker said after the bell Friday.Trials of the Lilly drug found that it helped reduce the number of breathing disruptions in an average night of sleep.

The Wall Street Journal on MSN · 2d

Eli Lilly Gets FDA Approval for Zepbound for Certain Sleep Apnea Patients

Eli Lilly said the FDA approved Zepbound for moderate-to-severe obstructive sleep apnea in adults with obesity, the first and only prescription medicine for those suffering from this condition.

ABC · 5d

FDA approves Eli Lilly’s obesity medication for obstructive sleep apnea

The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe obstructive sleep apnea for people with obesity.

MedCity News3d

Eli Lilly’s Zepbound Becomes First FDA-Approved Drug Therapy for Sleep Apnea

Sleep apnea, a sleep disorder typically managed with a medical device that aids in breathing, now has its first FDA-approved drug therapy, an Eli Lilly drug initially developed as a ...

NBC 10 Philadelphia5d

FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.

Eli Lilly expects to launch the drug for OSA at ... The index is used to evaluate the severity of obstructive sleep apnea and the effectiveness of treatments for the condition.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

obstructive sleep apnea, obesity and Zepbound

Trending now

Related topics